vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and STARZ ENTERTAINMENT CORP (STRZ). Click either name above to swap in a different company.
STARZ ENTERTAINMENT CORP is the larger business by last-quarter revenue ($320.9M vs $284.0M, roughly 1.1× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -16.4%, a 112.7% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -7.5%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -40.6%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Starz Entertainment Corp., formerly known as Lions Gate Entertainment Corporation, or simply Lionsgate, is a Canadian-American entertainment company currently headquartered in Santa Monica, California. Founded by Frank Giustra on July 10, 1997, it is/was domiciled and incorporated in Vancouver, British Columbia.
ACAD vs STRZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $320.9M |
| Net Profit | $273.6M | $-52.6M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | -10.8% |
| Net Margin | 96.3% | -16.4% |
| Revenue YoY | 9.4% | -7.5% |
| Net Profit YoY | 90.3% | -71.9% |
| EPS (diluted) | $1.61 | $-3.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $320.9M | ||
| Q2 25 | $264.6M | $319.7M | ||
| Q1 25 | $244.3M | — | ||
| Q4 24 | $259.6M | $970.5M | ||
| Q3 24 | $250.4M | $346.9M | ||
| Q2 24 | $242.0M | $347.6M | ||
| Q1 24 | $205.8M | — |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $-52.6M | ||
| Q2 25 | $26.7M | $-42.5M | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $143.7M | $-21.9M | ||
| Q3 24 | $32.8M | $-30.6M | ||
| Q2 24 | $33.4M | $4.2M | ||
| Q1 24 | $16.6M | — |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | -10.8% | ||
| Q2 25 | 12.2% | -8.4% | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 59.1% | 3.7% | ||
| Q3 24 | 12.6% | -4.9% | ||
| Q2 24 | 12.6% | 2.9% | ||
| Q1 24 | 7.4% | — |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | -16.4% | ||
| Q2 25 | 10.1% | -13.3% | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 55.4% | -2.3% | ||
| Q3 24 | 13.1% | -8.8% | ||
| Q2 24 | 13.8% | 1.2% | ||
| Q1 24 | 8.0% | — |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | $-3.15 | ||
| Q2 25 | $0.16 | $-2.54 | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.86 | $-0.09 | ||
| Q3 24 | $0.20 | $-1.83 | ||
| Q2 24 | $0.20 | $0.26 | ||
| Q1 24 | $0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $37.0M |
| Total DebtLower is stronger | — | $608.7M |
| Stockholders' EquityBook value | $1.2B | $663.2M |
| Total Assets | $1.6B | $2.0B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | $37.0M | ||
| Q2 25 | $253.6M | $51.6M | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | $200.5M | ||
| Q3 24 | $155.1M | $229.6M | ||
| Q2 24 | $177.1M | $192.5M | ||
| Q1 24 | $204.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $608.7M | ||
| Q2 25 | — | $611.7M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $663.2M | ||
| Q2 25 | $822.4M | $712.3M | ||
| Q1 25 | $765.2M | — | ||
| Q4 24 | $732.8M | $-168.3M | ||
| Q3 24 | $577.2M | $935.9M | ||
| Q2 24 | $516.7M | $973.1M | ||
| Q1 24 | $464.0M | — |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $2.0B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.2B | $7.2B | ||
| Q3 24 | $976.9M | $7.1B | ||
| Q2 24 | $914.1M | $7.2B | ||
| Q1 24 | $855.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.24× | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-26.1M |
| Free Cash FlowOCF − Capex | — | $-31.3M |
| FCF MarginFCF / Revenue | — | -9.8% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-317.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $-26.1M | ||
| Q2 25 | $64.0M | $65.4M | ||
| Q1 25 | $20.3M | — | ||
| Q4 24 | $40.4M | $-335.3M | ||
| Q3 24 | $63.2M | $9.1M | ||
| Q2 24 | $25.0M | $-33.5M | ||
| Q1 24 | $29.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $-31.3M | ||
| Q2 25 | — | $58.5M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-349.3M | ||
| Q3 24 | $63.2M | $4.4M | ||
| Q2 24 | — | $-38.4M | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | -9.8% | ||
| Q2 25 | — | 18.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -36.0% | ||
| Q3 24 | 25.2% | 1.3% | ||
| Q2 24 | — | -11.0% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | 0.0% | 1.4% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | — |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | -7.98× | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
STRZ
| Over The Top Subscription Service OTT | $222.8M | 69% |
| Linear Subscription Service | $98.1M | 31% |
